UNIVERSITY OF CALIFORNIA LOS ANGELES
Transcranial Electrical Stimulation in Stroke EaRly After onset Clinical Trial-2 (TESSERACT 2)
Transcranial Electrical Stimulation in Stroke EaRly After onset Clinical Trial-2 (TESSERACT 2) is a funding opportunity from UNIVERSITY OF CALIFORNIA LOS ANGELES, up to 776631, closing August 31, 2026.
Aug 31, 2026
(31d left)Overview
Acute ischemic stroke (AIS) is a leading cause of death and disability for which treatments are limited to reperfusion therapies, including intravenous thrombolytic (lytic) and endovascular thrombectomy (EVT). Many patients are not candidates for these therapies, and amongst those who receive them, the rate of…